Some people with SOD1-ALS experienced improvements in physical function and muscle strength after three years on Qalsody, an ...

Actor Eric Dane, who lives with ALS, has joined the board of directors of the U.S. nonprofit Target ALS, with an aim of ...

Our top 10 ALS news stories of 2025 feature actor Eric Dane’s advocacy and major research milestones in the field.

MyoRegulator, a device to be used at home to slow disability progression in ALS, has been granted breakthrough device ...

Columnist Dagmar Munn pens a letter to her younger self addressing early concerns about ALS, just after her diagnosis 15 years ago.

As columnist Kristin Neva reflects on 2025 and looks ahead to the new year, she finds hope even in the uncertainty of living with ALS.

NUZ-001, an investigational oral therapy for ALS, is officially the ninth compound to be included in the HEALEY ALS platform ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease in which muscles waste away due to the death of the nerve cells that control them. The condition affects limb function ...

A new formulation of MediciNova’s investigational amyotrophic lateral sclerosis treatment ibudilast (MN-166) given via an intravenous (into the vein) infusion was found to be safe and well tolerated ...

One of my biggest concerns is how my husband’s ALS will affect our children. They were both under 5 when Todd was diagnosed and while they are growing up, their father continues to lose strength. A ...

Relyvrio (sodium phenylbutyrate and taurursodiol), an approved treatment for people with amyotrophic lateral sclerosis (ALS), has failed to meet its primary goal of slowing disease progression in an ...